Made SA
Made SA (MLMAD.PA) Stock Competitors & Peer Comparison
See (MLMAD.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Hardware, Equipment & Parts Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MLMAD.PA | €11.70 | +0.00% | 15M | 13.45 | €0.87 | N/A |
| SESL.PA | €122.00 | +0.33% | 1.9B | 18.60 | €6.56 | N/A |
| BAR.BR | €9.31 | -1.64% | 797.5M | 11.19 | €0.85 | +4.59% |
| ALNSE.PA | €50.00 | +4.60% | 164.5M | 76.77 | €0.65 | +0.54% |
| PAY.BR | €6.90 | +0.73% | 121M | 12.45 | €0.55 | +3.78% |
| LACR.PA | €13.20 | +5.18% | 62M | -3.53 | -€3.74 | N/A |
| ALICA.PA | €4.22 | +2.68% | 35.6M | 9.02 | €0.49 | +2.94% |
| MLNOV.PA | €19.50 | +0.52% | 20M | 66.00 | €0.30 | N/A |
| ALGID.PA | €0.96 | +0.42% | 19.3M | -32.80 | -€0.03 | N/A |
| ALNEO.PA | €0.50 | +0.00% | 13M | 3.57 | €0.14 | N/A |
Stock Comparison
MLMAD.PA vs SESL.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, SESL.PA has a market cap of 1.9B. Regarding current trading prices, MLMAD.PA is priced at €11.70, while SESL.PA trades at €122.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas SESL.PA's P/E ratio is 18.60. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to SESL.PA's ROE of -0.10%. Regarding short-term risk, MLMAD.PA is less volatile compared to SESL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check SESL.PA's competition here
MLMAD.PA vs BAR.BR Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, BAR.BR has a market cap of 797.5M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while BAR.BR trades at €9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas BAR.BR's P/E ratio is 11.19. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to BAR.BR's ROE of +0.10%. Regarding short-term risk, MLMAD.PA is less volatile compared to BAR.BR. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check BAR.BR's competition here
MLMAD.PA vs ALNSE.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALNSE.PA has a market cap of 164.5M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALNSE.PA trades at €50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALNSE.PA's P/E ratio is 76.77. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALNSE.PA's ROE of +0.05%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALNSE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALNSE.PA's competition here
MLMAD.PA vs PAY.BR Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, PAY.BR has a market cap of 121M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while PAY.BR trades at €6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas PAY.BR's P/E ratio is 12.45. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to PAY.BR's ROE of +0.15%. Regarding short-term risk, MLMAD.PA and PAY.BR have similar daily volatility (0.00).Check PAY.BR's competition here
MLMAD.PA vs LACR.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, LACR.PA has a market cap of 62M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while LACR.PA trades at €13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas LACR.PA's P/E ratio is -3.53. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to LACR.PA's ROE of -0.32%. Regarding short-term risk, MLMAD.PA is less volatile compared to LACR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check LACR.PA's competition here
MLMAD.PA vs ALICA.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALICA.PA has a market cap of 35.6M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALICA.PA trades at €4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALICA.PA's P/E ratio is 9.02. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALICA.PA's ROE of -0.04%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALICA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALICA.PA's competition here
MLMAD.PA vs MLNOV.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, MLNOV.PA has a market cap of 20M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while MLNOV.PA trades at €19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas MLNOV.PA's P/E ratio is 66.00. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to MLNOV.PA's ROE of +0.03%. Regarding short-term risk, MLMAD.PA and MLNOV.PA have similar daily volatility (0.00).Check MLNOV.PA's competition here
MLMAD.PA vs ALGID.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALGID.PA has a market cap of 19.3M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALGID.PA trades at €0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALGID.PA's P/E ratio is -32.80. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALGID.PA's ROE of -0.60%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALGID.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALGID.PA's competition here
MLMAD.PA vs ALNEO.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALNEO.PA has a market cap of 13M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALNEO.PA trades at €0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALNEO.PA's P/E ratio is 3.57. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALNEO.PA's ROE of +0.80%. Regarding short-term risk, MLMAD.PA and ALNEO.PA have similar daily volatility (0.00).Check ALNEO.PA's competition here
MLMAD.PA vs ALCOF.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALCOF.PA has a market cap of 11.3M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALCOF.PA trades at €296.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALCOF.PA's P/E ratio is 9.61. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALCOF.PA's ROE of +0.04%. Regarding short-term risk, MLMAD.PA and ALCOF.PA have similar daily volatility (0.00).Check ALCOF.PA's competition here
MLMAD.PA vs ALGTR.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALGTR.PA has a market cap of 11.2M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALGTR.PA trades at €2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALGTR.PA's P/E ratio is -18.80. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALGTR.PA's ROE of -0.33%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALGTR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALGTR.PA's competition here
MLMAD.PA vs ALROC.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALROC.PA has a market cap of 5.7M. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALROC.PA trades at €0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALROC.PA's P/E ratio is -2.56. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALROC.PA's ROE of -1.41%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALROC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALROC.PA's competition here
MLMAD.PA vs ALTEV.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALTEV.PA has a market cap of 0. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALTEV.PA trades at €167.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALTEV.PA's P/E ratio is 49.29. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALTEV.PA's ROE of +0.07%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALTEV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALTEV.PA's competition here
MLMAD.PA vs GID.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, GID.PA has a market cap of 0. Regarding current trading prices, MLMAD.PA is priced at €11.70, while GID.PA trades at €0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas GID.PA's P/E ratio is 40.10. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to GID.PA's ROE of +0.02%. Regarding short-term risk, MLMAD.PA is less volatile compared to GID.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check GID.PA's competition here
MLMAD.PA vs ALM.PA Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, ALM.PA has a market cap of 0. Regarding current trading prices, MLMAD.PA is priced at €11.70, while ALM.PA trades at €2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas ALM.PA's P/E ratio is -8.54. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to ALM.PA's ROE of +0.80%. Regarding short-term risk, MLMAD.PA is less volatile compared to ALM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check ALM.PA's competition here
MLMAD.PA vs NEWAY.AS Comparison April 2026
MLMAD.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLMAD.PA stands at 15M. In comparison, NEWAY.AS has a market cap of 0. Regarding current trading prices, MLMAD.PA is priced at €11.70, while NEWAY.AS trades at €12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLMAD.PA currently has a P/E ratio of 13.45, whereas NEWAY.AS's P/E ratio is 17.96. In terms of profitability, MLMAD.PA's ROE is +0.25%, compared to NEWAY.AS's ROE of +0.08%. Regarding short-term risk, MLMAD.PA is less volatile compared to NEWAY.AS. This indicates potentially lower risk in terms of short-term price fluctuations for MLMAD.PA.Check NEWAY.AS's competition here